




已阅读5页,还剩30页未读, 继续免费阅读
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Prepared by:-Mohammad Ali Al-shehri.Supervised by : Dr.,Nephrotic Syndrome.(NS),Introduction,Definition of NSEtiology of NSPathology of NSPathophysiology of NS Clinical Manifestation of NSComplication NSLaboratory DataDiagnosisTreatment,Nephrotic syndrome,Nephrotic syndrome (NS) results from increased permeability of Glomeulrar basement membrane (GBM) to plasma protein. It is clinical and laboratory syndrome characterized by massive proteinuria, which lead to hypoproteinemia ( hypo-albuminemia), hyperlipidemia and pitting edema. (4-increase, 1-decrease).,Nephrotic Criteria:-,*Massive proteinuria: qualitative proteinuria: 3+ or 4+, quantitative proteinuria : more than 40 mg/m2/hr in children (selective). *Hypo-proteinemia : total plasma proteins 5.7mmol/L *Edema: pitting edema in different degree,Nephritic Criteria,-Hematuria: RBC in urine (gross hematuria) -Hypertension:130/90 mmHg in school-age children120/80 mmHg in preschool-age children110/70 mmHg in infant and toddlers children-Azotemia(renal insufficiency): Increased level of serum BUN 、Cr-Hypo-complementemia: Decreased level of serum c3,Classification:,A-Primary Idiopathic NS (INS): majority The cause is still unclear up to now. Recent 10 years ,increasing evidence has suggested that INS may result from a primary disorder of T cell function. Accounting for 90% of NS in child. mainly discussed.B-Secondary NS: NS resulted from systemic diseases, such as anaphylactoid purpura , systemic lupus erythematosus, HBV infection. C-Congenital NS: rare*1st 3monthe of life ,only treatment renal transplantation,Secondary NS,Drug,Toxic,Allegy: mercury, snake venom, vaccine, pellicillamine, Heroin, gold, NSAID, captopril, probenecid, volatile hydrocarbonsInfection: APSGN, HBV, HIV, shunt nephropathy, reflux nephropathy, leprosy, syphilis, Schistosomiasis, hydatid diseaseAutoimmune or collagen-vascular diseases: SLE, Hashimotos thyroiditis, HSP, VasculitisMetabolic disease: Diabetes mellitus Neoplasma: Hodgkins disease, carcinoma ( renal cell, lung, neuroblastoma, breast, and etc)Genetic Disease: Alport syn, Sickle cell disease, Amyloidosis, Congenital nephropathy Others: Chronic transplant rejection, congenital nephrosclerosis,Idiopathic NS (INS): Pathology:-,Minimal Change Nephropathy (MCN): 40mg/m2/hr for childrenc- volume: oliguria (during stage of edema formation)d-Microscopically:-microscopic hematuria 20%, large number of hyaline cast,Investigations:-,2-Blood:A-serum protein: decrease 5.5gm/dL , Albumin levels are low (2.5gm/dL). B-Serum cholesterol and triglycerides: Cholesterol 5.7mmol/L (220mg/dl).C- ESR100mm/hr during activity phase .3.Serum complemen: Vary with clinical type. 4.Renal function.,Kidney Biopsy:-,Considered in: 1-Secondary N.S 2-Frequent relapsing N.S 3-Steroid resistant N.S4- Hematuria5-Hypertension6- Low GFR,Differential Diagnosis of NS:,D.D of generalized edema:-1-Protein losing enteropathy2-Hepatic Failure.3-HF4-Protein energy malnutrition5-Acute and chronic GN6-urticaria? Angio edema,Complications of NS:-,1-Infections:Infections is a major complication in children with NS. It frequently trigger relapses.Nephrotic pt are liable to infection because :A-loss of immunoglobins in urine.B-the edema fluid act as a culture medium.C-use immunosuppressive agents.D- malnutritionThe common infection : URI, peritonitis, cellulitis and UTI may be seen.Organisms: encapsulated (Pneumococci, H.influenzae), Gram negative (e.g E.coli,Complication ,Vaccines in NS;-polyvalent pneumococcal vaccine (if not previously immunized) when the child is in remission and off daily prednisone therapy.Children with a negative varicella titer should be given varicella vaccine.,Complication.,2-Hypercoagulability (Thrombosis).Hypercoagulability of the blood leading to venous or arterial thrombosis:Hypercoagulability in Nephrotic syndrome caused by:1-Higher concentration of I,II, V,VII,VIII,X and fibrinogen 2- Lower level of anticoagulant substance: antithrombin III 3-decrease fibrinolysis. 4-Higher blood viscosity 5- Increased platelet aggregation6- Overaggressive diuresis,3-ARF: pre-renal and renal 4- cardiovascular disease :-Hyperlipidemia, may be a risk factor for cardiovascular disease.5-Hypovolemic shock6-Others: growth retardation, malnutrition, adrenal cortical insufficiency,Management of NS:,General (non-specific ) *Corticosteroid therapy,General therapy:-,Hospitalization:- for initial work-up and evaluation of treatment.Activity: usually no restriction , except massive edema,heavy hypertension and infection.Diet Hypertension and edema: Low salt diet ( 2 + protein for 7 consecutive days. *Frequent relapsing: 2 relapses within 6 months ( 4/year). *Steroid resistant: failure to achieve remission with prednisolone given daily for 28 days.,Side Effects With Long Term Use of Steroids “Steroid toxicity,hyperglycemiamyopathypeptic ulcerpoor healing of wound.HirsutismThromboembolism,-Stunted growthCataracts- Pseudotumor cerebri-Psycosis -Osteo
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025-2030动力总成电气化转型节奏与零部件投资优先级报告
- 2025-2030功能性运动内衣市场需求增长驱动因素报告
- 2025-2030共享经济行业市场供需状况及未来发展前景预测分析报告
- 2025年页岩气开采技术环境效益评估与能源结构调整报告
- 2025年风电技术创新在风电场风能利用效率中的应用分析报告
- 2025年放射科学影像识别与报告撰写能力测试卷答案及解析
- 2025年教师资格考试小学面试体育试题及解答参考
- 2025年农业面源污染治理技术创新与农业产业链绿色发展报告
- 2025年咖啡师职业技能测试卷:咖啡师行业市场调研与分析案例试题
- 2025年大学卫生教育专业题库- 医疗卫生资源与大学生的接触途径研究
- 庭院绿化施工方案
- 《大学语文》课件 第16讲 智在纵横 苏秦始将连横
- 医院工作纪律培训课件
- 营房装修施工方案(3篇)
- 开远美景家乡课件
- 2025至2030中国仿制药行业市场深度分析及前景趋势与投资报告
- 监测数据智能分析
- 临床基于ERAS理念下医护患一体化疼痛管理实践探索
- 外科术后患者营养宣教要点
- 安全技术交底书
- 统编版(2024)八年级上册道德与法治第一单元《走进社会生活》测试卷(含答案)
评论
0/150
提交评论